SCHEMBL5286548

SCHEMBL5286548

O=C(Cn1c(=O)oc2ccccc21)Oc1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.58
IDO1 P14902 2/20 0.57
LMNA P02545 2/20 0.53
ALDH1A1 P00352 1/20 0.52
HTT P42858 1/20 0.52
USP2 O75604 1/20 0.51
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51
CDYL Q9Y232 3/20 0.51
CBX7 O95931 2/20 0.51
CDYL2 Q8N8U2 2/20 0.51
CDY1; CDY1B Q9Y6F8 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
PKM P14618 1/20 0.51
CYP2C19 P33261 1/20 0.51
ATM Q13315 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5290934 0.84 MIF (0.50) ALDH1A1CYP1A2CYP2D6PKMCYP2C19
SCHEMBL5289506 0.84 L3MBTL1 (0.61) LMNAALDH1A1HTTTSHRMEN1
SCHEMBL6717405 0.82 HPGD (0.66) HPGDIDO1LMNAALDH1A1HTT
SCHEMBL5282646 0.81 KMT2A (0.42) HPGDIDO1LMNAALDH1A1HTT
SCHEMBL10444126 0.80 ALDH1A1 (0.64) HPGDLMNAALDH1A1HTTUSP2
SCHEMBL5283365 0.80 HPGD (0.62) HPGDIDO1LMNAALDH1A1HTT
SCHEMBL13995838 0.77 HPGD (0.71) HPGDIDO1LMNAALDH1A1HTT
SCHEMBL5328824 0.76 ALDH1A1 (0.58) LMNAALDH1A1TSHRMAPK1MEN1
SCHEMBL5288497 0.76 LMNA (0.52) LMNAALDH1A1TSHRCYP1A2MEN1
SCHEMBL2947194 0.75 HPGD (0.73) HPGDIDO1LMNAALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001335-A2 RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-01-04 WO disclosed
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity CLSPN, LMAN2, RPN2 HPGD 1825/4885IDO1 1993/4885LMNA 3704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.